Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral TherapyDiana Finzi, Robert F. Siliciano, Monika Hermankova et al.|Science|1997Cited by 3.1k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Susan E. Dorman et al.|Clinical Infectious Diseases|2016Cited by 1.5k
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E. Dorman, Richard E. Chaisson, Payam Nahid et al.|New England Journal of Medicine|2021Cited by 548
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsMark Sulkowski, Richard D. Moore, David L. Thomas et al.|Hepatology|2002Cited by 521
Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-AnalysisAmitabh B. Suthar, Reuben Granich, Stephen D Lawn et al.|PLoS Medicine|2012Cited by 413